Back

Longitudinal change in epicardial adipose tissue attenuation on serial non-contrast chest CT in finerenone-treated patients: a real-world cohort study

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Xinyu Zhang

Xi'an (China)

7 More presentations in this session

Presentation thumbnail
Impact of cumulative contrast volume on medium- to long-term renal function in patients undergoing repeated percutaneous coronary interventions
Doctor P. Steinhoff (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of echocardiographic cardiac deterioration after arteriovenous access surgery
Doctor L. Fisher (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
CV inflammation prevalence and clinical biomarkers (hsCRP, IL-6 and NT-proBNP) levels in adults with ASCVD and CKD in KSA and UAE: Insights from the INFLAMEAST real‑world study
Doctor M. Alasnag (Jeddah, SA)
Abstract Slides Video
Presentation thumbnail
Glp-1 receptor agonists and cardiovascular outcomes in obese patients on dialysis:insights –from the TriNetX real-world database
Mrs B. Prado (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor and cardiovascular outcomes among patients with diabetes on dialysis:– insights from the TriNetX real-world database
Mrs B. Prado (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between epicardial adipose tissue attenuation and long-term clinical outcomes after transcatheter aortic valve replacement
30 August 2026
thumbnail
Congress Presentation
Effects of finerenone in patients with hypertensive nephropathy
30 August 2026
thumbnail
Congress Presentation
Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
1 September 2024
thumbnail
Congress Presentation
Thickness of epicardial adipose tissue reflects the metabolic and cardiovascular status of patients in T1DM population
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources